|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SERPINA3-LAP3 (FusionGDB2 ID:80171) |
Fusion Gene Summary for SERPINA3-LAP3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: SERPINA3-LAP3 | Fusion gene ID: 80171 | Hgene | Tgene | Gene symbol | SERPINA3 | LAP3 | Gene ID | 12 | 51056 |
Gene name | serpin family A member 3 | leucine aminopeptidase 3 | |
Synonyms | AACT|ACT|GIG24|GIG25 | HEL-S-106|LAP|LAPEP|PEPS | |
Cytomap | 14q32.13 | 4p15.32 | |
Type of gene | protein-coding | protein-coding | |
Description | alpha-1-antichymotrypsincell growth-inhibiting gene 24/25 proteingrowth-inhibiting protein 24growth-inhibiting protein 25serine (or cysteine) proteinase inhibitor, clade A, member 3serpin A3serpin peptidase inhibitor, clade A (alpha-1 antiproteinase | cytosol aminopeptidaseLAP-3epididymis secretory protein Li 106leucyl aminopeptidasepeptidase Sproline aminopeptidaseprolyl aminopeptidase | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | P28838 | |
Ensembl transtripts involved in fusion gene | ENST00000393078, ENST00000485588, ENST00000393080, ENST00000467132, ENST00000482740, | ENST00000226299, ENST00000606142, ENST00000503467, | |
Fusion gene scores | * DoF score | 10 X 12 X 5=600 | 8 X 7 X 7=392 |
# samples | 12 | 8 | |
** MAII score | log2(12/600*10)=-2.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/392*10)=-2.29278174922785 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SERPINA3 [Title/Abstract] AND LAP3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SERPINA3(95090392)-LAP3(17585225), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | SERPINA3-LAP3 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. SERPINA3-LAP3 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across SERPINA3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across LAP3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LIHC | TCGA-HP-A5MZ-01A | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
Top |
Fusion Gene ORF analysis for SERPINA3-LAP3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000393078 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
In-frame | ENST00000393078 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
5CDS-intron | ENST00000393078 | ENST00000503467 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
intron-3CDS | ENST00000485588 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
intron-3CDS | ENST00000485588 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
intron-intron | ENST00000485588 | ENST00000503467 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
In-frame | ENST00000393080 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
In-frame | ENST00000393080 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
5CDS-intron | ENST00000393080 | ENST00000503467 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
Frame-shift | ENST00000467132 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
Frame-shift | ENST00000467132 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
5CDS-intron | ENST00000467132 | ENST00000503467 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
In-frame | ENST00000482740 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
In-frame | ENST00000482740 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
5CDS-intron | ENST00000482740 | ENST00000503467 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000393078 | SERPINA3 | chr14 | 95090392 | - | ENST00000226299 | LAP3 | chr4 | 17585225 | + | 3029 | 1589 | 4 | 1350 | 448 |
ENST00000393078 | SERPINA3 | chr14 | 95090392 | - | ENST00000606142 | LAP3 | chr4 | 17585225 | + | 2995 | 1589 | 4 | 1350 | 448 |
ENST00000393080 | SERPINA3 | chr14 | 95090392 | - | ENST00000226299 | LAP3 | chr4 | 17585225 | + | 3021 | 1581 | 62 | 1339 | 425 |
ENST00000393080 | SERPINA3 | chr14 | 95090392 | - | ENST00000606142 | LAP3 | chr4 | 17585225 | + | 2987 | 1581 | 62 | 1339 | 425 |
ENST00000482740 | SERPINA3 | chr14 | 95090392 | - | ENST00000226299 | LAP3 | chr4 | 17585225 | + | 3860 | 2420 | 2416 | 3480 | 354 |
ENST00000482740 | SERPINA3 | chr14 | 95090392 | - | ENST00000606142 | LAP3 | chr4 | 17585225 | + | 3826 | 2420 | 2416 | 3480 | 354 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000393078 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + | 0.002471706 | 0.99752825 |
ENST00000393078 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + | 0.002510212 | 0.9974898 |
ENST00000393080 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + | 0.000697397 | 0.9993026 |
ENST00000393080 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + | 0.000716813 | 0.99928325 |
ENST00000482740 | ENST00000226299 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + | 0.000441742 | 0.99955827 |
ENST00000482740 | ENST00000606142 | SERPINA3 | chr14 | 95090392 | - | LAP3 | chr4 | 17585225 | + | 0.000429842 | 0.9995702 |
Top |
Fusion Genomic Features for SERPINA3-LAP3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SERPINA3-LAP3 |
Go to FGviewer for the breakpoints of chr14:95090392-chr4:17585225 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | LAP3 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Cytolosic metallopeptidase that catalyzes the removal of unsubstituted N-terminal hydrophobic amino acids from various peptides. The presence of Zn(2+) ions is essential for the peptidase activity, and the association with other cofactors can modulate the substrate spectificity of the enzyme. For instance, in the presence of Mn(2+), it displays a specific Cys-Gly hydrolyzing activity of Cys-Gly-S-conjugates. Involved in the metabolism of glutathione and in the degradation of glutathione S-conjugates, which may play a role in the control of the cell redox status. {ECO:0000250|UniProtKB:P00727}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000393078 | - | 5 | 5 | 235_237 | 503.3333333333333 | 424.0 | DNA binding | . |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000393080 | - | 5 | 5 | 235_237 | 504.3333333333333 | 424.0 | DNA binding | . |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000467132 | - | 5 | 5 | 235_237 | 504.0 | 424.0 | DNA binding | . |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000393078 | - | 5 | 5 | 369_394 | 503.3333333333333 | 424.0 | Region | Note=RCL |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000393078 | - | 5 | 5 | 381_389 | 503.3333333333333 | 424.0 | Region | Note=O-glycosylated at one site |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000393080 | - | 5 | 5 | 369_394 | 504.3333333333333 | 424.0 | Region | Note=RCL |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000393080 | - | 5 | 5 | 381_389 | 504.3333333333333 | 424.0 | Region | Note=O-glycosylated at one site |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000467132 | - | 5 | 5 | 369_394 | 504.0 | 424.0 | Region | Note=RCL |
Hgene | SERPINA3 | chr14:95090392 | chr4:17585225 | ENST00000467132 | - | 5 | 5 | 381_389 | 504.0 | 424.0 | Region | Note=O-glycosylated at one site |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for SERPINA3-LAP3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000393078_ENST00000226299_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(transcript)=3029nt_BP=1589nt ATTCATGAAAATCCACTACTCCAGACAGACGGCTTTGGAATCCACCAGCTACATCCAGCTCCCTGAGGCAGAGTTGAGAATGGAGAGAAT GTTACCTCTCCTGGCTCTGGGGCTCTTGGCGGCTGGGTTCTGCCCTGCTGTCCTCTGCCACCCTAACAGCCCACTTGACGAGGAGAATCT GACCCAGGAGAACCAAGACCGAGGGACACACGTGGACCTCGGATTAGCCTCCGCCAACGTGGACTTCGCTTTCAGCCTGTACAAGCAGTT AGTCCTGAAGGCCCCTGATAAGAATGTCATCTTCTCCCCACTGAGCATCTCCACCGCCTTGGCCTTCCTGTCTCTGGGGGCCCATAATAC CACCCTGACAGAGATTCTCAAAGGCCTCAAGTTCAACCTCACGGAGACTTCTGAGGCAGAAATTCACCAGAGCTTCCAGCACCTCCTGCG CACCCTCAATCAGTCCAGCGATGAGCTGCAGCTGAGTATGGGAAATGCCATGTTTGTCAAAGAGCAACTCAGTCTGCTGGACAGGTTCAC GGAGGATGCCAAGAGGCTGTATGGCTCCGAGGCCTTTGCCACTGACTTTCAGGACTCAGCTGCAGCTAAGAAGCTCATCAACGACTACGT GAAGAATGGAACTAGGGGGAAAATCACAGATCTGATCAAGGACCTTGACTCGCAGACAATGATGGTCCTGGTGAATTACATCTTCTTTAA AGCCAAATGGGAGATGCCCTTTGACCCCCAAGATACTCATCAGTCAAGGTTCTACTTGAGCAAGAAAAAGTGGGTAATGGTGCCCATGAT GAGTTTGCATCACCTGACTATACCTTACTTCCGGGACGAGGAGCTGTCCTGCACCGTGGTGGAGCTGAAGTACACAGGCAATGCCAGCGC ACTCTTCATCCTCCCTGATCAAGACAAGATGGAGGAAGTGGAAGCCATGCTGCTCCCAGAGACCCTGAAGCGGTGGAGAGACTCTCTGGA GTTCAGAGAGATAGGTGAGCTCTACCTGCCAAAGTTTTCCATCTCGAGGGACTATAACCTGAACGACATACTTCTCCAGCTGGGCATTGA GGAAGCCTTCACCAGCAAGGCTGACCTGTCAGGGATCACAGGGGCCAGGAACCTAGCAGTCTCCCAGGTGGTCCATAAGGCTGTGCTTGA TGTATTTGAGGAGGGCACAGAAGCATCTGCTGCCACAGCAGTCAAAATCACCCTCCTTTCTGCATTAGTGGAGACAAGGACCATTGTGCG TTTCAACAGGCCCTTCCTGATGATCATTGTCCCTACAGACACCCAGAACATCTTCTTCATGAGCAAAGTCACCAATCCCAAGCAAGCCTA GAGCTTGCCATCAAGCAGTGGGGCTCTCAGTAAGGAACTTGGAATGCAAGCTGGATGCCTGGGTCTCTGGGCACAGCCTGGCCCCTGTGC ACCGAGTGGCCATGGCATGTGTGGCCCTGTCTGCTTATCCTTGGAAGGTGACAGCGATTCCCTGTGTAGCTCTCACATGCACAGGGGCCC ATGGACTCTTCAGTCTGGAGGGTCCTGGGCCTCCTGACAGCAATAAATAATTTCGTTGGAAAAAAAGAAGATGGCTGTGTCGGCAAAGCT CTATGGAAGTGGGGATCAGGAGGCCTGGCAGAAAGGAGTCCTGTTTGCTTCTGGGCAGAACTTGGCACGCCAATTGATGGAGACGCCAGC CAATGAGATGACGCCAACCAGATTTGCTGAAATTATTGAGAAGAATCTCAAAAGTGCTAGTAGTAAAACCGAGGTCCATATCAGACCCAA GTCTTGGATTGAGGAACAGGCAATGGGATCATTCCTCAGTGTGGCCAAAGGATCTGACGAGCCCCCAGTCTTCTTGGAAATTCACTACAA AGGCAGCCCCAATGCAAACGAACCACCCCTGGTGTTTGTTGGGAAAGGAATTACCTTTGACAGTGGTGGTATCTCCATCAAGGCTTCTGC AAATATGGACCTCATGAGGGCTGACATGGGAGGAGCTGCAACTATATGCTCAGCCATCGTGTCTGCTGCAAAGCTTAATTTGCCCATTAA TATTATAGGTCTGGCCCCTCTTTGTGAAAATATGCCCAGCGGCAAGGCCAACAAGCCGGGGGATGTTGTTAGAGCCAAAAACGGGAAGAC CATCCAGGTTGATAACACTGATGCTGAGGGGAGGCTCATACTGGCTGATGCGCTCTGTTACGCACACACGTTTAACCCGAAGGTCATCCT CAATGCCGCCACCTTAACAGGTGCCATGGATGTAGCTTTGGGATCAGGTGCCACTGGGGTCTTTACCAATTCATCCTGGCTCTGGAACAA ACTCTTCGAGGCCAGCATTGAAACAGGGGACCGTGTCTGGAGGATGCCTCTCTTCGAACATTATACAAGACAGGTTGTAGATTGCCAGCT TGCTGATGTTAACAACATTGGAAAATACAGATCTGCAGGAGCATGTACAGCTGCAGCATTCCTGAAAGAATTCGTAACTCATCCTAAGTG GGCACATTTAGACATAGCAGGCGTGATGACCAACAAAGATGAAGTTCCCTATCTACGGAAAGGCATGACTGGGAGGCCCACAAGGACTCT CATTGAGTTCTTACTTCGTTTCAGTCAAGACAATGCTTAGTTCAGATACTCAAAAATGTCTTCACTCTGTCTTAAATTGGACAGTTGAAC TTAAAAGGTTTTTGAATAAATGGATGAAAATCTTTTAACGGAGACAAAGGATGGTATTTAAAAATGTAGAACACAATGAAATTTGTATGC CTTGATTTTTTTTTCATTTCACACAAAGATTTATAAAGGTAAAGTTAATATCTTACTTGATAAGGATTTTTAAGATACTCTATAAATGAT TAAAATTTTTAGAACTTCCTAATCACTTTTCAGAGTATATGTTTTTCATTGAGAAGCAAAATTGTAACTCAGATTTGTGATGCTAGGAAC >In-frame_ENST00000393078_ENST00000226299_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(amino acids)=448AA_start in transcript=4_stop in transcript=1350 MKIHYSRQTALESTSYIQLPEAELRMERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLV LKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTE DAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMS LHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEE -------------------------------------------------------------- >In-frame_ENST00000393078_ENST00000606142_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(transcript)=2995nt_BP=1589nt ATTCATGAAAATCCACTACTCCAGACAGACGGCTTTGGAATCCACCAGCTACATCCAGCTCCCTGAGGCAGAGTTGAGAATGGAGAGAAT GTTACCTCTCCTGGCTCTGGGGCTCTTGGCGGCTGGGTTCTGCCCTGCTGTCCTCTGCCACCCTAACAGCCCACTTGACGAGGAGAATCT GACCCAGGAGAACCAAGACCGAGGGACACACGTGGACCTCGGATTAGCCTCCGCCAACGTGGACTTCGCTTTCAGCCTGTACAAGCAGTT AGTCCTGAAGGCCCCTGATAAGAATGTCATCTTCTCCCCACTGAGCATCTCCACCGCCTTGGCCTTCCTGTCTCTGGGGGCCCATAATAC CACCCTGACAGAGATTCTCAAAGGCCTCAAGTTCAACCTCACGGAGACTTCTGAGGCAGAAATTCACCAGAGCTTCCAGCACCTCCTGCG CACCCTCAATCAGTCCAGCGATGAGCTGCAGCTGAGTATGGGAAATGCCATGTTTGTCAAAGAGCAACTCAGTCTGCTGGACAGGTTCAC GGAGGATGCCAAGAGGCTGTATGGCTCCGAGGCCTTTGCCACTGACTTTCAGGACTCAGCTGCAGCTAAGAAGCTCATCAACGACTACGT GAAGAATGGAACTAGGGGGAAAATCACAGATCTGATCAAGGACCTTGACTCGCAGACAATGATGGTCCTGGTGAATTACATCTTCTTTAA AGCCAAATGGGAGATGCCCTTTGACCCCCAAGATACTCATCAGTCAAGGTTCTACTTGAGCAAGAAAAAGTGGGTAATGGTGCCCATGAT GAGTTTGCATCACCTGACTATACCTTACTTCCGGGACGAGGAGCTGTCCTGCACCGTGGTGGAGCTGAAGTACACAGGCAATGCCAGCGC ACTCTTCATCCTCCCTGATCAAGACAAGATGGAGGAAGTGGAAGCCATGCTGCTCCCAGAGACCCTGAAGCGGTGGAGAGACTCTCTGGA GTTCAGAGAGATAGGTGAGCTCTACCTGCCAAAGTTTTCCATCTCGAGGGACTATAACCTGAACGACATACTTCTCCAGCTGGGCATTGA GGAAGCCTTCACCAGCAAGGCTGACCTGTCAGGGATCACAGGGGCCAGGAACCTAGCAGTCTCCCAGGTGGTCCATAAGGCTGTGCTTGA TGTATTTGAGGAGGGCACAGAAGCATCTGCTGCCACAGCAGTCAAAATCACCCTCCTTTCTGCATTAGTGGAGACAAGGACCATTGTGCG TTTCAACAGGCCCTTCCTGATGATCATTGTCCCTACAGACACCCAGAACATCTTCTTCATGAGCAAAGTCACCAATCCCAAGCAAGCCTA GAGCTTGCCATCAAGCAGTGGGGCTCTCAGTAAGGAACTTGGAATGCAAGCTGGATGCCTGGGTCTCTGGGCACAGCCTGGCCCCTGTGC ACCGAGTGGCCATGGCATGTGTGGCCCTGTCTGCTTATCCTTGGAAGGTGACAGCGATTCCCTGTGTAGCTCTCACATGCACAGGGGCCC ATGGACTCTTCAGTCTGGAGGGTCCTGGGCCTCCTGACAGCAATAAATAATTTCGTTGGAAAAAAAGAAGATGGCTGTGTCGGCAAAGCT CTATGGAAGTGGGGATCAGGAGGCCTGGCAGAAAGGAGTCCTGTTTGCTTCTGGGCAGAACTTGGCACGCCAATTGATGGAGACGCCAGC CAATGAGATGACGCCAACCAGATTTGCTGAAATTATTGAGAAGAATCTCAAAAGTGCTAGTAGTAAAACCGAGGTCCATATCAGACCCAA GTCTTGGATTGAGGAACAGGCAATGGGATCATTCCTCAGTGTGGCCAAAGGATCTGACGAGCCCCCAGTCTTCTTGGAAATTCACTACAA AGGCAGCCCCAATGCAAACGAACCACCCCTGGTGTTTGTTGGGAAAGGAATTACCTTTGACAGTGGTGGTATCTCCATCAAGGCTTCTGC AAATATGGACCTCATGAGGGCTGACATGGGAGGAGCTGCAACTATATGCTCAGCCATCGTGTCTGCTGCAAAGCTTAATTTGCCCATTAA TATTATAGGTCTGGCCCCTCTTTGTGAAAATATGCCCAGCGGCAAGGCCAACAAGCCGGGGGATGTTGTTAGAGCCAAAAACGGGAAGAC CATCCAGGTTGATAACACTGATGCTGAGGGGAGGCTCATACTGGCTGATGCGCTCTGTTACGCACACACGTTTAACCCGAAGGTCATCCT CAATGCCGCCACCTTAACAGGTGCCATGGATGTAGCTTTGGGATCAGGTGCCACTGGGGTCTTTACCAATTCATCCTGGCTCTGGAACAA ACTCTTCGAGGCCAGCATTGAAACAGGGGACCGTGTCTGGAGGATGCCTCTCTTCGAACATTATACAAGACAGGTTGTAGATTGCCAGCT TGCTGATGTTAACAACATTGGAAAATACAGATCTGCAGGAGCATGTACAGCTGCAGCATTCCTGAAAGAATTCGTAACTCATCCTAAGTG GGCACATTTAGACATAGCAGGCGTGATGACCAACAAAGATGAAGTTCCCTATCTACGGAAAGGCATGACTGGGAGGCCCACAAGGACTCT CATTGAGTTCTTACTTCGTTTCAGTCAAGACAATGCTTAGTTCAGATACTCAAAAATGTCTTCACTCTGTCTTAAATTGGACAGTTGAAC TTAAAAGGTTTTTGAATAAATGGATGAAAATCTTTTAACGGAGACAAAGGATGGTATTTAAAAATGTAGAACACAATGAAATTTGTATGC CTTGATTTTTTTTTCATTTCACACAAAGATTTATAAAGGTAAAGTTAATATCTTACTTGATAAGGATTTTTAAGATACTCTATAAATGAT TAAAATTTTTAGAACTTCCTAATCACTTTTCAGAGTATATGTTTTTCATTGAGAAGCAAAATTGTAACTCAGATTTGTGATGCTAGGAAC >In-frame_ENST00000393078_ENST00000606142_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(amino acids)=448AA_start in transcript=4_stop in transcript=1350 MKIHYSRQTALESTSYIQLPEAELRMERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLV LKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTE DAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMS LHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEE -------------------------------------------------------------- >In-frame_ENST00000393080_ENST00000226299_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(transcript)=3021nt_BP=1581nt AAAATCCACTACTCCAGACAGACGGCTTTGGAATCCACCAGCTACATCCAGCTCCCTGAGAGTTGAGAATGGAGAGAATGTTACCTCTCC TGGCTCTGGGGCTCTTGGCGGCTGGGTTCTGCCCTGCTGTCCTCTGCCACCCTAACAGCCCACTTGACGAGGAGAATCTGACCCAGGAGA ACCAAGACCGAGGGACACACGTGGACCTCGGATTAGCCTCCGCCAACGTGGACTTCGCTTTCAGCCTGTACAAGCAGTTAGTCCTGAAGG CCCCTGATAAGAATGTCATCTTCTCCCCACTGAGCATCTCCACCGCCTTGGCCTTCCTGTCTCTGGGGGCCCATAATACCACCCTGACAG AGATTCTCAAAGGCCTCAAGTTCAACCTCACGGAGACTTCTGAGGCAGAAATTCACCAGAGCTTCCAGCACCTCCTGCGCACCCTCAATC AGTCCAGCGATGAGCTGCAGCTGAGTATGGGAAATGCCATGTTTGTCAAAGAGCAACTCAGTCTGCTGGACAGGTTCACGGAGGATGCCA AGAGGCTGTATGGCTCCGAGGCCTTTGCCACTGACTTTCAGGACTCAGCTGCAGCTAAGAAGCTCATCAACGACTACGTGAAGAATGGAA CTAGGGGGAAAATCACAGATCTGATCAAGGACCTTGACTCGCAGACAATGATGGTCCTGGTGAATTACATCTTCTTTAAAGCCAAATGGG AGATGCCCTTTGACCCCCAAGATACTCATCAGTCAAGGTTCTACTTGAGCAAGAAAAAGTGGGTAATGGTGCCCATGATGAGTTTGCATC ACCTGACTATACCTTACTTCCGGGACGAGGAGCTGTCCTGCACCGTGGTGGAGCTGAAGTACACAGGCAATGCCAGCGCACTCTTCATCC TCCCTGATCAAGACAAGATGGAGGAAGTGGAAGCCATGCTGCTCCCAGAGACCCTGAAGCGGTGGAGAGACTCTCTGGAGTTCAGAGAGA TAGGTGAGCTCTACCTGCCAAAGTTTTCCATCTCGAGGGACTATAACCTGAACGACATACTTCTCCAGCTGGGCATTGAGGAAGCCTTCA CCAGCAAGGCTGACCTGTCAGGGATCACAGGGGCCAGGAACCTAGCAGTCTCCCAGGTGGTCCATAAGGCTGTGCTTGATGTATTTGAGG AGGGCACAGAAGCATCTGCTGCCACAGCAGTCAAAATCACCCTCCTTTCTGCATTAGTGGAGACAAGGACCATTGTGCGTTTCAACAGGC CCTTCCTGATGATCATTGTCCCTACAGACACCCAGAACATCTTCTTCATGAGCAAAGTCACCAATCCCAAGCAAGCCTAGAGCTTGCCAT CAAGCAGTGGGGCTCTCAGTAAGGAACTTGGAATGCAAGCTGGATGCCTGGGTCTCTGGGCACAGCCTGGCCCCTGTGCACCGAGTGGCC ATGGCATGTGTGGCCCTGTCTGCTTATCCTTGGAAGGTGACAGCGATTCCCTGTGTAGCTCTCACATGCACAGGGGCCCATGGACTCTTC AGTCTGGAGGGTCCTGGGCCTCCTGACAGCAATAAATAATTTCGTTGGACAAAAAAAAGAAGATGGCTGTGTCGGCAAAGCTCTATGGAA GTGGGGATCAGGAGGCCTGGCAGAAAGGAGTCCTGTTTGCTTCTGGGCAGAACTTGGCACGCCAATTGATGGAGACGCCAGCCAATGAGA TGACGCCAACCAGATTTGCTGAAATTATTGAGAAGAATCTCAAAAGTGCTAGTAGTAAAACCGAGGTCCATATCAGACCCAAGTCTTGGA TTGAGGAACAGGCAATGGGATCATTCCTCAGTGTGGCCAAAGGATCTGACGAGCCCCCAGTCTTCTTGGAAATTCACTACAAAGGCAGCC CCAATGCAAACGAACCACCCCTGGTGTTTGTTGGGAAAGGAATTACCTTTGACAGTGGTGGTATCTCCATCAAGGCTTCTGCAAATATGG ACCTCATGAGGGCTGACATGGGAGGAGCTGCAACTATATGCTCAGCCATCGTGTCTGCTGCAAAGCTTAATTTGCCCATTAATATTATAG GTCTGGCCCCTCTTTGTGAAAATATGCCCAGCGGCAAGGCCAACAAGCCGGGGGATGTTGTTAGAGCCAAAAACGGGAAGACCATCCAGG TTGATAACACTGATGCTGAGGGGAGGCTCATACTGGCTGATGCGCTCTGTTACGCACACACGTTTAACCCGAAGGTCATCCTCAATGCCG CCACCTTAACAGGTGCCATGGATGTAGCTTTGGGATCAGGTGCCACTGGGGTCTTTACCAATTCATCCTGGCTCTGGAACAAACTCTTCG AGGCCAGCATTGAAACAGGGGACCGTGTCTGGAGGATGCCTCTCTTCGAACATTATACAAGACAGGTTGTAGATTGCCAGCTTGCTGATG TTAACAACATTGGAAAATACAGATCTGCAGGAGCATGTACAGCTGCAGCATTCCTGAAAGAATTCGTAACTCATCCTAAGTGGGCACATT TAGACATAGCAGGCGTGATGACCAACAAAGATGAAGTTCCCTATCTACGGAAAGGCATGACTGGGAGGCCCACAAGGACTCTCATTGAGT TCTTACTTCGTTTCAGTCAAGACAATGCTTAGTTCAGATACTCAAAAATGTCTTCACTCTGTCTTAAATTGGACAGTTGAACTTAAAAGG TTTTTGAATAAATGGATGAAAATCTTTTAACGGAGACAAAGGATGGTATTTAAAAATGTAGAACACAATGAAATTTGTATGCCTTGATTT TTTTTTCATTTCACACAAAGATTTATAAAGGTAAAGTTAATATCTTACTTGATAAGGATTTTTAAGATACTCTATAAATGATTAAAATTT TTAGAACTTCCTAATCACTTTTCAGAGTATATGTTTTTCATTGAGAAGCAAAATTGTAACTCAGATTTGTGATGCTAGGAACATGAGCAA >In-frame_ENST00000393080_ENST00000226299_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(amino acids)=425AA_start in transcript=62_stop in transcript=1339 MRMERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLS LGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKK LINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKY TGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVV -------------------------------------------------------------- >In-frame_ENST00000393080_ENST00000606142_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(transcript)=2987nt_BP=1581nt AAAATCCACTACTCCAGACAGACGGCTTTGGAATCCACCAGCTACATCCAGCTCCCTGAGAGTTGAGAATGGAGAGAATGTTACCTCTCC TGGCTCTGGGGCTCTTGGCGGCTGGGTTCTGCCCTGCTGTCCTCTGCCACCCTAACAGCCCACTTGACGAGGAGAATCTGACCCAGGAGA ACCAAGACCGAGGGACACACGTGGACCTCGGATTAGCCTCCGCCAACGTGGACTTCGCTTTCAGCCTGTACAAGCAGTTAGTCCTGAAGG CCCCTGATAAGAATGTCATCTTCTCCCCACTGAGCATCTCCACCGCCTTGGCCTTCCTGTCTCTGGGGGCCCATAATACCACCCTGACAG AGATTCTCAAAGGCCTCAAGTTCAACCTCACGGAGACTTCTGAGGCAGAAATTCACCAGAGCTTCCAGCACCTCCTGCGCACCCTCAATC AGTCCAGCGATGAGCTGCAGCTGAGTATGGGAAATGCCATGTTTGTCAAAGAGCAACTCAGTCTGCTGGACAGGTTCACGGAGGATGCCA AGAGGCTGTATGGCTCCGAGGCCTTTGCCACTGACTTTCAGGACTCAGCTGCAGCTAAGAAGCTCATCAACGACTACGTGAAGAATGGAA CTAGGGGGAAAATCACAGATCTGATCAAGGACCTTGACTCGCAGACAATGATGGTCCTGGTGAATTACATCTTCTTTAAAGCCAAATGGG AGATGCCCTTTGACCCCCAAGATACTCATCAGTCAAGGTTCTACTTGAGCAAGAAAAAGTGGGTAATGGTGCCCATGATGAGTTTGCATC ACCTGACTATACCTTACTTCCGGGACGAGGAGCTGTCCTGCACCGTGGTGGAGCTGAAGTACACAGGCAATGCCAGCGCACTCTTCATCC TCCCTGATCAAGACAAGATGGAGGAAGTGGAAGCCATGCTGCTCCCAGAGACCCTGAAGCGGTGGAGAGACTCTCTGGAGTTCAGAGAGA TAGGTGAGCTCTACCTGCCAAAGTTTTCCATCTCGAGGGACTATAACCTGAACGACATACTTCTCCAGCTGGGCATTGAGGAAGCCTTCA CCAGCAAGGCTGACCTGTCAGGGATCACAGGGGCCAGGAACCTAGCAGTCTCCCAGGTGGTCCATAAGGCTGTGCTTGATGTATTTGAGG AGGGCACAGAAGCATCTGCTGCCACAGCAGTCAAAATCACCCTCCTTTCTGCATTAGTGGAGACAAGGACCATTGTGCGTTTCAACAGGC CCTTCCTGATGATCATTGTCCCTACAGACACCCAGAACATCTTCTTCATGAGCAAAGTCACCAATCCCAAGCAAGCCTAGAGCTTGCCAT CAAGCAGTGGGGCTCTCAGTAAGGAACTTGGAATGCAAGCTGGATGCCTGGGTCTCTGGGCACAGCCTGGCCCCTGTGCACCGAGTGGCC ATGGCATGTGTGGCCCTGTCTGCTTATCCTTGGAAGGTGACAGCGATTCCCTGTGTAGCTCTCACATGCACAGGGGCCCATGGACTCTTC AGTCTGGAGGGTCCTGGGCCTCCTGACAGCAATAAATAATTTCGTTGGACAAAAAAAAGAAGATGGCTGTGTCGGCAAAGCTCTATGGAA GTGGGGATCAGGAGGCCTGGCAGAAAGGAGTCCTGTTTGCTTCTGGGCAGAACTTGGCACGCCAATTGATGGAGACGCCAGCCAATGAGA TGACGCCAACCAGATTTGCTGAAATTATTGAGAAGAATCTCAAAAGTGCTAGTAGTAAAACCGAGGTCCATATCAGACCCAAGTCTTGGA TTGAGGAACAGGCAATGGGATCATTCCTCAGTGTGGCCAAAGGATCTGACGAGCCCCCAGTCTTCTTGGAAATTCACTACAAAGGCAGCC CCAATGCAAACGAACCACCCCTGGTGTTTGTTGGGAAAGGAATTACCTTTGACAGTGGTGGTATCTCCATCAAGGCTTCTGCAAATATGG ACCTCATGAGGGCTGACATGGGAGGAGCTGCAACTATATGCTCAGCCATCGTGTCTGCTGCAAAGCTTAATTTGCCCATTAATATTATAG GTCTGGCCCCTCTTTGTGAAAATATGCCCAGCGGCAAGGCCAACAAGCCGGGGGATGTTGTTAGAGCCAAAAACGGGAAGACCATCCAGG TTGATAACACTGATGCTGAGGGGAGGCTCATACTGGCTGATGCGCTCTGTTACGCACACACGTTTAACCCGAAGGTCATCCTCAATGCCG CCACCTTAACAGGTGCCATGGATGTAGCTTTGGGATCAGGTGCCACTGGGGTCTTTACCAATTCATCCTGGCTCTGGAACAAACTCTTCG AGGCCAGCATTGAAACAGGGGACCGTGTCTGGAGGATGCCTCTCTTCGAACATTATACAAGACAGGTTGTAGATTGCCAGCTTGCTGATG TTAACAACATTGGAAAATACAGATCTGCAGGAGCATGTACAGCTGCAGCATTCCTGAAAGAATTCGTAACTCATCCTAAGTGGGCACATT TAGACATAGCAGGCGTGATGACCAACAAAGATGAAGTTCCCTATCTACGGAAAGGCATGACTGGGAGGCCCACAAGGACTCTCATTGAGT TCTTACTTCGTTTCAGTCAAGACAATGCTTAGTTCAGATACTCAAAAATGTCTTCACTCTGTCTTAAATTGGACAGTTGAACTTAAAAGG TTTTTGAATAAATGGATGAAAATCTTTTAACGGAGACAAAGGATGGTATTTAAAAATGTAGAACACAATGAAATTTGTATGCCTTGATTT TTTTTTCATTTCACACAAAGATTTATAAAGGTAAAGTTAATATCTTACTTGATAAGGATTTTTAAGATACTCTATAAATGATTAAAATTT TTAGAACTTCCTAATCACTTTTCAGAGTATATGTTTTTCATTGAGAAGCAAAATTGTAACTCAGATTTGTGATGCTAGGAACATGAGCAA >In-frame_ENST00000393080_ENST00000606142_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(amino acids)=425AA_start in transcript=62_stop in transcript=1339 MRMERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLS LGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKK LINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKY TGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVV -------------------------------------------------------------- >In-frame_ENST00000482740_ENST00000226299_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(transcript)=3860nt_BP=2420nt AAGTTGACCTGGGCCCATTTGAAAATTCCTTTTGCTCCCTCATTTTAACCCCTAAAGTAAAGCCGTTTGTGACTTTATGAGCTTTTACCA AGCATCTCCTAAAACCAAGAATGGAGGTGAAAGATTGTGGAGCCCACAACCTAGAGAAAGGATTGACAATTTTTTTTCCATAAAGGGCCT AGTAGTATGTATTTTAGGCTGTGTGGTCCACATGAGGGCAGATTCTTCTTTTTGACTTCCTCCTCTGCATCTTCTTCATCTTCTCTTTCC TCTTCATTTTTTTTACAACCTTTGAAAAATATAAGCACCATTCTTAGCTTTAGGTACACACAAAAATAAGCTATGGCTGTATTGGCTTAC AGGCTATAGTTTCCTGACCCCTGTTCTAGGGGAGGAAAATAATTGTACCCAACTAAATGCGTGCGAATCATGGGCCTATGTCATGATTCC CAAAGAATGAGTTTCATGGAATTTTCAACATTTTAAATATTTTACTCCATTCTTCCCTTGCTTGCATAGTTTCTGATGAGAAGTCTGCTG TCATTTTCATCCTTATTCCTTTTTAGATAAGGTGGAGTTTTCCTCCCTCTGCCTCTACCTCTACCTCTTTCAAGATTTTCTCTTTCTCTT TACTATGGTAAATAGGCCTTTAGTGAGAGGAGTTATGTCAGCCTGGCTAGGAGTCAGGCTGCATTTCAGGTTTGTGATAGCTAGAGGTAC CAGAGGCAGTTTCATGGAATTTTACCTTTGCAACACTGAGAGCCTAGGCAGCCTCAGAGTCAGAACACCCACAGTTGAATCCTCAGCCTG ACAGACACTGAATCCAGGGCAAATCTTAGCTGAATATTCATGGTCTGTAGAGGTGGACATGAGCTAGATATGAGCTAAGGACCATAGCCA GCTCATGGCTTTTGTGATGTCCAACACCGCTATCCTCTAAGATGTCACAAGTGTCCCTAGGCTTTTATTCCCATGGTCTCTCCTGGCTCT GAGTTCTATCTTCCATTAAGGTTCTTCCTGTTCCTCCCCTCATTCACACTGATTGGCATCTCTTCTGTCTGCCCTCACCAACTCACATAC AGAACCCAGTCTCTTTCCTCTTATTTCCACCCAAAGCCCTCCCACAAGCCACTGTTATATGTTCACATCCCTGTAATACCAGTGAGTAAT AATTGCTAATGAGACATTTTTCCTTTTATGGAACAAAGGCTGTCCCATTTCTCCTCAGGCACCAGCCTCCCACATGTTGTCATGCCTCTT TCCCCCACTTTCCCTAAACCTTCTTTCTCTCTTGCACTCCTTATTCCCTGGTTCCTATTGATTTCTCATTTAGCACAAGGAACTAGGTCT TTCTTTTGTGGCCCTTTTCCCAATCCAAGCCTGCTGGGCTCTCCCTCACCCCCAATAACTTTTACTCTTGCCAAGCTACTTCTCTAAACC AAAGCAGGGTCCCTCCTATGAGGGACTCTGGGCACTTCCACTGCTGCGGAAGCAGGGTCGAGCAGGGCGACCCTTGCACTCACACCTTCT CCAACTGCTTGCTCCACCTTCAGCCAAATGGGAGATGCCCTTTGACCCCCAAGATACTCATCAGTCAAGGTTCTACTTGAGCAAGAAAAA GTGGGTAATGGTGCCCATGATGAGTTTGCATCACCTGACTATACCTTACTTCCGGGACGAGGAGCTGTCCTGCACCGTGGTGGAGCTGAA GTACACAGGCAATGCCAGCGCACTCTTCATCCTCCCTGATCAAGACAAGATGGAGGAAGTGGAAGCCATGCTGCTCCCAGAGACCCTGAA GCGGTGGAGAGACTCTCTGGAGTTCAGAGAGATAGGTGAGCTCTACCTGCCAAAGTTTTCCATCTCGAGGGACTATAACCTGAACGACAT ACTTCTCCAGCTGGGCATTGAGGAAGCCTTCACCAGCAAGGCTGACCTGTCAGGGATCACAGGGGCCAGGAACCTAGCAGTCTCCCAGGT GGTCCATAAGGCTGTGCTTGATGTATTTGAGGAGGGCACAGAAGCATCTGCTGCCACAGCAGTCAAAATCACCCTCCTTTCTGCATTAGT GGAGACAAGGACCATTGTGCGTTTCAACAGGCCCTTCCTGATGATCATTGTCCCTACAGACACCCAGAACATCTTCTTCATGAGCAAAGT CACCAATCCCAAGCAAGCCTAGAGCTTGCCATCAAGCAGTGGGGCTCTCAGTAAGGAACTTGGAATGCAAGCTGGATGCCTGGGTCTCTG GGCACAGCCTGGCCCCTGTGCACCGAGTGGCCATGGCATGTGTGGCCCTGTCTGCTTATCCTTGGAAGGTGACAGCGATTCCCTGTGTAG CTCTCACATGCACAGGGGCCCATGGACTCTTCAGTCTGGAGGGTCCTGGGCCTCCTGACAGCAATAAATAATTTCGTTGGAAAAAAAGAA GATGGCTGTGTCGGCAAAGCTCTATGGAAGTGGGGATCAGGAGGCCTGGCAGAAAGGAGTCCTGTTTGCTTCTGGGCAGAACTTGGCACG CCAATTGATGGAGACGCCAGCCAATGAGATGACGCCAACCAGATTTGCTGAAATTATTGAGAAGAATCTCAAAAGTGCTAGTAGTAAAAC CGAGGTCCATATCAGACCCAAGTCTTGGATTGAGGAACAGGCAATGGGATCATTCCTCAGTGTGGCCAAAGGATCTGACGAGCCCCCAGT CTTCTTGGAAATTCACTACAAAGGCAGCCCCAATGCAAACGAACCACCCCTGGTGTTTGTTGGGAAAGGAATTACCTTTGACAGTGGTGG TATCTCCATCAAGGCTTCTGCAAATATGGACCTCATGAGGGCTGACATGGGAGGAGCTGCAACTATATGCTCAGCCATCGTGTCTGCTGC AAAGCTTAATTTGCCCATTAATATTATAGGTCTGGCCCCTCTTTGTGAAAATATGCCCAGCGGCAAGGCCAACAAGCCGGGGGATGTTGT TAGAGCCAAAAACGGGAAGACCATCCAGGTTGATAACACTGATGCTGAGGGGAGGCTCATACTGGCTGATGCGCTCTGTTACGCACACAC GTTTAACCCGAAGGTCATCCTCAATGCCGCCACCTTAACAGGTGCCATGGATGTAGCTTTGGGATCAGGTGCCACTGGGGTCTTTACCAA TTCATCCTGGCTCTGGAACAAACTCTTCGAGGCCAGCATTGAAACAGGGGACCGTGTCTGGAGGATGCCTCTCTTCGAACATTATACAAG ACAGGTTGTAGATTGCCAGCTTGCTGATGTTAACAACATTGGAAAATACAGATCTGCAGGAGCATGTACAGCTGCAGCATTCCTGAAAGA ATTCGTAACTCATCCTAAGTGGGCACATTTAGACATAGCAGGCGTGATGACCAACAAAGATGAAGTTCCCTATCTACGGAAAGGCATGAC TGGGAGGCCCACAAGGACTCTCATTGAGTTCTTACTTCGTTTCAGTCAAGACAATGCTTAGTTCAGATACTCAAAAATGTCTTCACTCTG TCTTAAATTGGACAGTTGAACTTAAAAGGTTTTTGAATAAATGGATGAAAATCTTTTAACGGAGACAAAGGATGGTATTTAAAAATGTAG AACACAATGAAATTTGTATGCCTTGATTTTTTTTTCATTTCACACAAAGATTTATAAAGGTAAAGTTAATATCTTACTTGATAAGGATTT TTAAGATACTCTATAAATGATTAAAATTTTTAGAACTTCCTAATCACTTTTCAGAGTATATGTTTTTCATTGAGAAGCAAAATTGTAACT >In-frame_ENST00000482740_ENST00000226299_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(amino acids)=354AA_start in transcript=2416_stop in transcript=3480 MEKKKMAVSAKLYGSGDQEAWQKGVLFASGQNLARQLMETPANEMTPTRFAEIIEKNLKSASSKTEVHIRPKSWIEEQAMGSFLSVAKGS DEPPVFLEIHYKGSPNANEPPLVFVGKGITFDSGGISIKASANMDLMRADMGGAATICSAIVSAAKLNLPINIIGLAPLCENMPSGKANK PGDVVRAKNGKTIQVDNTDAEGRLILADALCYAHTFNPKVILNAATLTGAMDVALGSGATGVFTNSSWLWNKLFEASIETGDRVWRMPLF -------------------------------------------------------------- >In-frame_ENST00000482740_ENST00000606142_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(transcript)=3826nt_BP=2420nt AAGTTGACCTGGGCCCATTTGAAAATTCCTTTTGCTCCCTCATTTTAACCCCTAAAGTAAAGCCGTTTGTGACTTTATGAGCTTTTACCA AGCATCTCCTAAAACCAAGAATGGAGGTGAAAGATTGTGGAGCCCACAACCTAGAGAAAGGATTGACAATTTTTTTTCCATAAAGGGCCT AGTAGTATGTATTTTAGGCTGTGTGGTCCACATGAGGGCAGATTCTTCTTTTTGACTTCCTCCTCTGCATCTTCTTCATCTTCTCTTTCC TCTTCATTTTTTTTACAACCTTTGAAAAATATAAGCACCATTCTTAGCTTTAGGTACACACAAAAATAAGCTATGGCTGTATTGGCTTAC AGGCTATAGTTTCCTGACCCCTGTTCTAGGGGAGGAAAATAATTGTACCCAACTAAATGCGTGCGAATCATGGGCCTATGTCATGATTCC CAAAGAATGAGTTTCATGGAATTTTCAACATTTTAAATATTTTACTCCATTCTTCCCTTGCTTGCATAGTTTCTGATGAGAAGTCTGCTG TCATTTTCATCCTTATTCCTTTTTAGATAAGGTGGAGTTTTCCTCCCTCTGCCTCTACCTCTACCTCTTTCAAGATTTTCTCTTTCTCTT TACTATGGTAAATAGGCCTTTAGTGAGAGGAGTTATGTCAGCCTGGCTAGGAGTCAGGCTGCATTTCAGGTTTGTGATAGCTAGAGGTAC CAGAGGCAGTTTCATGGAATTTTACCTTTGCAACACTGAGAGCCTAGGCAGCCTCAGAGTCAGAACACCCACAGTTGAATCCTCAGCCTG ACAGACACTGAATCCAGGGCAAATCTTAGCTGAATATTCATGGTCTGTAGAGGTGGACATGAGCTAGATATGAGCTAAGGACCATAGCCA GCTCATGGCTTTTGTGATGTCCAACACCGCTATCCTCTAAGATGTCACAAGTGTCCCTAGGCTTTTATTCCCATGGTCTCTCCTGGCTCT GAGTTCTATCTTCCATTAAGGTTCTTCCTGTTCCTCCCCTCATTCACACTGATTGGCATCTCTTCTGTCTGCCCTCACCAACTCACATAC AGAACCCAGTCTCTTTCCTCTTATTTCCACCCAAAGCCCTCCCACAAGCCACTGTTATATGTTCACATCCCTGTAATACCAGTGAGTAAT AATTGCTAATGAGACATTTTTCCTTTTATGGAACAAAGGCTGTCCCATTTCTCCTCAGGCACCAGCCTCCCACATGTTGTCATGCCTCTT TCCCCCACTTTCCCTAAACCTTCTTTCTCTCTTGCACTCCTTATTCCCTGGTTCCTATTGATTTCTCATTTAGCACAAGGAACTAGGTCT TTCTTTTGTGGCCCTTTTCCCAATCCAAGCCTGCTGGGCTCTCCCTCACCCCCAATAACTTTTACTCTTGCCAAGCTACTTCTCTAAACC AAAGCAGGGTCCCTCCTATGAGGGACTCTGGGCACTTCCACTGCTGCGGAAGCAGGGTCGAGCAGGGCGACCCTTGCACTCACACCTTCT CCAACTGCTTGCTCCACCTTCAGCCAAATGGGAGATGCCCTTTGACCCCCAAGATACTCATCAGTCAAGGTTCTACTTGAGCAAGAAAAA GTGGGTAATGGTGCCCATGATGAGTTTGCATCACCTGACTATACCTTACTTCCGGGACGAGGAGCTGTCCTGCACCGTGGTGGAGCTGAA GTACACAGGCAATGCCAGCGCACTCTTCATCCTCCCTGATCAAGACAAGATGGAGGAAGTGGAAGCCATGCTGCTCCCAGAGACCCTGAA GCGGTGGAGAGACTCTCTGGAGTTCAGAGAGATAGGTGAGCTCTACCTGCCAAAGTTTTCCATCTCGAGGGACTATAACCTGAACGACAT ACTTCTCCAGCTGGGCATTGAGGAAGCCTTCACCAGCAAGGCTGACCTGTCAGGGATCACAGGGGCCAGGAACCTAGCAGTCTCCCAGGT GGTCCATAAGGCTGTGCTTGATGTATTTGAGGAGGGCACAGAAGCATCTGCTGCCACAGCAGTCAAAATCACCCTCCTTTCTGCATTAGT GGAGACAAGGACCATTGTGCGTTTCAACAGGCCCTTCCTGATGATCATTGTCCCTACAGACACCCAGAACATCTTCTTCATGAGCAAAGT CACCAATCCCAAGCAAGCCTAGAGCTTGCCATCAAGCAGTGGGGCTCTCAGTAAGGAACTTGGAATGCAAGCTGGATGCCTGGGTCTCTG GGCACAGCCTGGCCCCTGTGCACCGAGTGGCCATGGCATGTGTGGCCCTGTCTGCTTATCCTTGGAAGGTGACAGCGATTCCCTGTGTAG CTCTCACATGCACAGGGGCCCATGGACTCTTCAGTCTGGAGGGTCCTGGGCCTCCTGACAGCAATAAATAATTTCGTTGGAAAAAAAGAA GATGGCTGTGTCGGCAAAGCTCTATGGAAGTGGGGATCAGGAGGCCTGGCAGAAAGGAGTCCTGTTTGCTTCTGGGCAGAACTTGGCACG CCAATTGATGGAGACGCCAGCCAATGAGATGACGCCAACCAGATTTGCTGAAATTATTGAGAAGAATCTCAAAAGTGCTAGTAGTAAAAC CGAGGTCCATATCAGACCCAAGTCTTGGATTGAGGAACAGGCAATGGGATCATTCCTCAGTGTGGCCAAAGGATCTGACGAGCCCCCAGT CTTCTTGGAAATTCACTACAAAGGCAGCCCCAATGCAAACGAACCACCCCTGGTGTTTGTTGGGAAAGGAATTACCTTTGACAGTGGTGG TATCTCCATCAAGGCTTCTGCAAATATGGACCTCATGAGGGCTGACATGGGAGGAGCTGCAACTATATGCTCAGCCATCGTGTCTGCTGC AAAGCTTAATTTGCCCATTAATATTATAGGTCTGGCCCCTCTTTGTGAAAATATGCCCAGCGGCAAGGCCAACAAGCCGGGGGATGTTGT TAGAGCCAAAAACGGGAAGACCATCCAGGTTGATAACACTGATGCTGAGGGGAGGCTCATACTGGCTGATGCGCTCTGTTACGCACACAC GTTTAACCCGAAGGTCATCCTCAATGCCGCCACCTTAACAGGTGCCATGGATGTAGCTTTGGGATCAGGTGCCACTGGGGTCTTTACCAA TTCATCCTGGCTCTGGAACAAACTCTTCGAGGCCAGCATTGAAACAGGGGACCGTGTCTGGAGGATGCCTCTCTTCGAACATTATACAAG ACAGGTTGTAGATTGCCAGCTTGCTGATGTTAACAACATTGGAAAATACAGATCTGCAGGAGCATGTACAGCTGCAGCATTCCTGAAAGA ATTCGTAACTCATCCTAAGTGGGCACATTTAGACATAGCAGGCGTGATGACCAACAAAGATGAAGTTCCCTATCTACGGAAAGGCATGAC TGGGAGGCCCACAAGGACTCTCATTGAGTTCTTACTTCGTTTCAGTCAAGACAATGCTTAGTTCAGATACTCAAAAATGTCTTCACTCTG TCTTAAATTGGACAGTTGAACTTAAAAGGTTTTTGAATAAATGGATGAAAATCTTTTAACGGAGACAAAGGATGGTATTTAAAAATGTAG AACACAATGAAATTTGTATGCCTTGATTTTTTTTTCATTTCACACAAAGATTTATAAAGGTAAAGTTAATATCTTACTTGATAAGGATTT TTAAGATACTCTATAAATGATTAAAATTTTTAGAACTTCCTAATCACTTTTCAGAGTATATGTTTTTCATTGAGAAGCAAAATTGTAACT >In-frame_ENST00000482740_ENST00000606142_TCGA-HP-A5MZ-01A_SERPINA3_chr14_95090392_-_LAP3_chr4_17585225_length(amino acids)=354AA_start in transcript=2416_stop in transcript=3480 MEKKKMAVSAKLYGSGDQEAWQKGVLFASGQNLARQLMETPANEMTPTRFAEIIEKNLKSASSKTEVHIRPKSWIEEQAMGSFLSVAKGS DEPPVFLEIHYKGSPNANEPPLVFVGKGITFDSGGISIKASANMDLMRADMGGAATICSAIVSAAKLNLPINIIGLAPLCENMPSGKANK PGDVVRAKNGKTIQVDNTDAEGRLILADALCYAHTFNPKVILNAATLTGAMDVALGSGATGVFTNSSWLWNKLFEASIETGDRVWRMPLF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SERPINA3-LAP3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SERPINA3-LAP3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SERPINA3-LAP3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SERPINA3 | C0023794 | Lipoidosis | 3 | CTD_human |
Hgene | SERPINA3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | SERPINA3 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Tgene | LAP3 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | LAP3 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | LAP3 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | LAP3 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | LAP3 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | LAP3 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |